Investigational schizophrenia medication (Phase 2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational schizophrenia medication (Phase 2), covering 2011-03-01 to 2011-03-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia [Phase 2]